Results 241 to 250 of about 424,248 (339)

Epidermal growth factor receptor, p16, cyclin D1, and p53 staining patterns for inverted papilloma

, 2013
Giant Lin, Adam Scheel, Sarah R. Akkina, Steven B. Chinn, Martin P. Graham, Christine M. Komarck, Heather M. Walline, Jonathan B. McHugh, Mark E. Prince, Thomas E. Carey, Mark A. Zacharek   +10 more
openalex   +2 more sources

Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients [PDF]

, 2010
William Sterlacci, Michael Fiegl, Wolfgang Hilbe, Herbert Jamnig, Wilhelm Oberaigner, Thomas Schmid, Florian Augustin, Jutta Auberger, Ellen C. Obermann, Alexandar Tzankov   +9 more
openalex   +1 more source

Ginkgolic Acid Inhibits VSMC Proliferation and Migration and Vascular Restenosis by Regulating Cell Cycle Progression and Cytoskeleton Rearrangement Through TCTN1. [PDF]

Cells
Shao Y, Yi L, Zhu Q, Zhou Y, Chen T, Yao W.   +5 more
europepmc   +1 more source

Protein inhibitor of activated STAT xα depresses cyclin D and cyclin D kinase, and contributes to the inhibition of osteosarcoma cell progression

, 2015
Junjie Wang, Jiangdong Ni, Shuai Yi, Deye Song, Muliang Ding   +4 more
openalex   +2 more sources

Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells [PDF]

, 2017
Jun Wang, Lihong Chang, Xiaoping Lai, Xia Li, Zhiyuan Wang, Zizhen Huang, Jiancong Huang, Gehua Zhang   +7 more
openalex   +1 more source

Combination of cyclin-dependent kinase 4/6 inhibitors and renin-angiotensin system inhibitors in breast cancer treatment: a promising therapeutic approach. [PDF]

Rev Assoc Med Bras (1992)
Mutlu E, İnanç M.
europepmc   +1 more source

Coupled Transcriptional and Translational Control of Cyclin-Dependent Kinase Inhibitor p18^INK4cExpression during Myogenesis

, 1998
Dawn E. Phelps, Kuang-Ming Hsiao, Yan Li, Nanpin Hu, David S. Franklin, Eva Westphal, Eva Y.-H. P. Lee, Yue Xiong   +7 more
openalex   +2 more sources

Cyclin D1 (CCND1); cyclin D2 (CCND2) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Cyclins and cyclin-dependent kinases: a biochemical view [PDF]

Biochemical Journal, 1995
openaire   +2 more sources

Somatic cell reprogramming for Parkinson's disease treatment

Ibrain, Volume 11, Issue 1, Page 59-73, Spring 2025.
The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley   +1 more source